Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Roffi

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Gastroenterology|January 1, 1987
Somatosensory evoked potentials in hepatic encephalopathyV Crespi, L Roffi
Italian Journal of Gastroenterology and Hepatology|October 6, 1998
"Breakthrough" during interferon therapy for chronic hepatitis C. Overview on the diagnosis, possible aetiology and recommendations for managementG Colloredo, L Roffi, G Bellati
Hepatology (Baltimore, Md.)|February 15, 2001
Psychological screening before interferon therapyA Scalori, P Apale, L Roffi
Clinical Chemistry|February 1, 1977
Immunoelectrophoretic quantitation of alpha-fetoproteinM Pietrogrande, L Roffi, A S Bassi, et al.
Liver|June 1, 1984
Decrease in suppressor/cytotoxic T-cells with histamine receptors in patients with chronic active hepatitisM Colombo, M G Rumi, L Roffi, et al.
The New Microbiologica|November 5, 2003
Helicobacter pylori infection in patients with Hepatitis C Virus positive chronic liver diseasesA Ponzetto, R Pellicano, A Redaelli, et al.
The American Journal of Gastroenterology|October 1, 1996
Breakthrough of interferon therapyA Scalori, A Ricci, G Bellati, et al.
Journal of Hepatology|February 1, 1997
Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.GG Bellati, G Colloredo, L Roffi, et al.
Archives of Virology. Supplementum|January 1, 1992
Hepatitis C virus infection in patients with idiopathic hemochromatosis (IH) and porphyria cutanea tarda (PCT)A Piperno, R D'Alba, L Roffi, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|May 1, 1991
[Intrahepatic cholestasis in pregnancy: incidence, clinical course, complications]N Roncaglia, D Trio, L Roffi, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Gastroenterology|January 1, 1987
Somatosensory evoked potentials in hepatic encephalopathyV Crespi, L Roffi
Italian Journal of Gastroenterology and Hepatology|October 6, 1998
"Breakthrough" during interferon therapy for chronic hepatitis C. Overview on the diagnosis, possible aetiology and recommendations for managementG Colloredo, L Roffi, G Bellati
Hepatology (Baltimore, Md.)|February 15, 2001
Psychological screening before interferon therapyA Scalori, P Apale, L Roffi
Clinical Chemistry|February 1, 1977
Immunoelectrophoretic quantitation of alpha-fetoproteinM Pietrogrande, L Roffi, A S Bassi, et al.
Liver|June 1, 1984
Decrease in suppressor/cytotoxic T-cells with histamine receptors in patients with chronic active hepatitisM Colombo, M G Rumi, L Roffi, et al.
The New Microbiologica|November 5, 2003
Helicobacter pylori infection in patients with Hepatitis C Virus positive chronic liver diseasesA Ponzetto, R Pellicano, A Redaelli, et al.
The American Journal of Gastroenterology|October 1, 1996
Breakthrough of interferon therapyA Scalori, A Ricci, G Bellati, et al.
Journal of Hepatology|February 1, 1997
Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.GG Bellati, G Colloredo, L Roffi, et al.
Archives of Virology. Supplementum|January 1, 1992
Hepatitis C virus infection in patients with idiopathic hemochromatosis (IH) and porphyria cutanea tarda (PCT)A Piperno, R D'Alba, L Roffi, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|May 1, 1991
[Intrahepatic cholestasis in pregnancy: incidence, clinical course, complications]N Roncaglia, D Trio, L Roffi, et al.
Pageof 4